Curcumin and silibinin inhibit telomerase expression in T47D human breast cancer cells

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 6, 2013, Pages 3449-3453

  Nasiri, Marzieh ^a   Zarghami, Nosratollah ^a   Koshki, Kazem Nejati ^a   Mollazadeh, Mahdieh ^a   Moghaddam, Mohammad Pourhassan ^a   Yamchi, Mohammad Rahmati ^a   Esfahlan, Rana Jahanban ^a   Barkhordari, Amin ^a   Alibakhshi, Abbas ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Curcumin; Silibinin; Telomerase

Indexed keywords

EID: 84882630611     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.6.3449     Document Type: Article

References (25)

1. Bundred NJ (2001). Prognostic and predictive factors in breast cancer. Cancer Treat Rev, 27, 137-42.
2. Chakravarti N, Kadara H, Yoon DJ, et al (2010). Differential inhibition of protein translation machinery by
3. Choudhuri T, Pal S, Agwarwal ML, Das T, Sa G (2002). Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett, 512, 334-40.
4. Jemal A, Siegel R, Xu J, Ward E (2010). Cancer statistics. CA Cancer J Clin, 60, 277-300.
5. Ju Z, Rudolph KL (2006). Telomeres and telomerase in cancer stem cells. Eur J Cancer, 42, 1197-203.
6. Kaur M, Velmurugan B, Tyagi A, et al (2009). Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft. Mol Cancer Ther, 8, 2366-74.
7. Kim S, Choi JH, Lim HI, et al (2009). Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells. Phytomedicine, 16, 573-80.
8. Lin CJ, Sukarieh R, Pelletier J (2009). Silibinin inhibits translation initiation: implications for anticancer therapy. Mol Cancer Ther, 8, 1606-12.
9. Massard C, Zermati Y, Pauleau AL, et al (2006). hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway. Oncogene, 25, 4505-14.
10. Mukherjee Nee Chakraborty S, Ghosh U, Bhattacharyya NP, Dey S, Roy M (2007). Curcumin-induced apoptosis in human leukemia cell HL-60 is associated with inhibition of telomerase activity. Mol Cell Biochem, 297, 31-9.
11. Nakamura M, Masutomi K, Kyo S, et al (2005). Efficient inhibition of human telomerase reverse transcriptase expression by RNA interference sensitizes cancer cells to ionizing radiation and chemotherapy. Hum Gene Ther, 16, 859-68.
12. Ramachandran C, You W (1999). Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin. Breast Cancer Res Treat, 54, 269-78.
13. Ramachandran C, Fonseca HB, Jhabvala P, Escalon EA, Melnick SJ (2002). Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line. Cancer Lett, 184, 1-6.
14. Sa G, Das T (1997). Anti cancer effects of curcumin: cycle of life and death. Cell Div, 3, 14.
15. Shay JW, Gazdar AF (1997). Telomerase in the early detection of cancer. J Clin Pathol, 50, 106-9.
16. Subramaniam D, Ponnurangam S, Ramamoorthy P, et al (2012). Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling. PLoS One, 7, 30590.
17. Syng-Ai C, Kumari AL, Khar A (2004). Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther, 3, 1101-18.
18. Thelen P, Wuttke W, Jarry H, Grzmil M, Ringert RH (2004). Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells. J Urol, 171, 1934-8.
19. Tyagi AK, Agarwal C, Chan DC, Agarwal R (2004). Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells. Oncol Rep, 11, 493-9.
20. Wang HJ, Jiang YY, Wei XF, et al (2010). Silibinin induces protective superoxide generation in human breast cancer MCF-7 cells. Free Radic Res, 44, 90-100.
21. Wang L, Soria JC, Kemp BL, et al (2002). hTERT expression is a prognostic factor of survival in patients with stage I nonsmall cell lung cancer. Clin Cancer Res, 8, 2883-9.
22. Watson JL, Greenshields A, Hill R, et al (2010). Curcumininduced apoptosis in ovarian carcinoma cells is p53- independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling. Mol Carcinog, 49, 13-24.
23. Wilken R, Veena MS, Wang MB, Srivatsan ES (2011). Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer, 10, 12.
24. Yeo M, Rha SY, Jeung HC, et al (2005). Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells. Int J Cancer, 114, 484-9.
25. Zou L, Zhang P, Luo C, Tu Z (2006). Mad1 suppresses bladder cancer cell proliferation by inhibiting human telomerase reverse transcriptase transcription and telomerase activity. Urology, 67, 1335-40.